Akoya Biosciences Inc
NASDAQ:AKYA
Akoya Biosciences Inc
Revenue
Akoya Biosciences Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Akoya Biosciences Inc
NASDAQ:AKYA
|
Revenue
$96.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Akoya Biosciences Inc
Revenue Breakdown
Breakdown by Geography
Akoya Biosciences Inc
Total Revenue:
96.6m
USD
|
North America:
58.3m
USD
|
EMEA:
21.8m
USD
|
Apac:
16.6m
USD
|
Breakdown by Segments
Akoya Biosciences Inc
Total Revenue:
96.6m
USD
|
Product:
67.4m
USD
|
Instruments:
42.1m
USD
|
Service And Other:
29.2m
USD
|
Consumables:
24.1m
USD
|
Standalone Software Products:
1.2m
USD
|
See Also
What is Akoya Biosciences Inc's Revenue?
Revenue
96.6m
USD
Based on the financial report for Dec 31, 2023, Akoya Biosciences Inc's Revenue amounts to 96.6m USD.
What is Akoya Biosciences Inc's Revenue growth rate?
Revenue CAGR 3Y
32%
Over the last year, the Revenue growth was 29%. The average annual Revenue growth rates for Akoya Biosciences Inc have been 32% over the past three years .